Goldline Pharmaceutical Limited
ListedSMEHealthcare · BSE
Goldline Pharmaceuticals markets pharmaceutical products under the “Goldline” brand, offering a wide range of medicines across five divisions—Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. These products cater to various medical specialties including physicians, cardiologists, pediatricians, orthopedics, neurologists, critical care experts, and cancer supportive care. Instead of manufacturing medicines directly, the company works with third-party manufacturers who produce products based on its research and specifications while ensuring quality and regulatory compliance. Goldline sells its products through a network of distributors, retailers, and wholesalers, and also supports hospitals and healthcare providers with procurement and supply services. The company currently partners with 15 manufacturers and 7 distributors, with operations spread across states like Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.
Price Band
₹41 – ₹43
Issue Size
₹270.00 L Cr
Lot Size
3000 shares
GMP
₹12
+27.9%
Est. Listing
₹55
at current GMP
Subscribed
840.81x
overall
Open
12 May 2026
Close
14 May 2026
Allotment
15 May 2026
Refund
16 May 2026
Demat Credit
17 May 2026
Listing
19 May 2026
Last updated 4 months ago
Official Registrar Verification
Goldline Pharmaceutical Limited Allotment Status
Designated Registrar: Bigshare Services Private Limited
Allotment Date
15 May 2026
Basis finalization
Refunds Initiate
16 May 2026
Mandate release
Demat Credit
17 May 2026
Shares in demat
Listing Debut
19 May 2026
Trading begins
How to Check Goldline Pharmaceutical Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Bigshare Services Private Limited's allotment portal.
- Select Goldline Pharmaceutical Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Goldline Pharmaceutical Limited Public Issue & Market Profile
Goldline Pharmaceutical Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹27,00,000 Crores. The shares are offered at a price band of ₹41 to ₹43 per equity share on BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Allotment Procedure:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Official Allotment Timelines & Registrar Guidance:
Following the close of bidding on 2026-05-14, the basis of allotment is scheduled to be finalized on 2026-05-15. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.